Skip to main content

and
Your search also matched 5 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial

Include preview-only content
  1. Article

    Open Access

    An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial

    A novel avian influenza subtype, A/H7N9, emerged in 2013 and represents a public health threat with pandemic potential. We have previously shown that DNA vaccine priming increases the magnitude and quality of ...

    Adam D. DeZure, Emily E. Coates, Zonghui Hu, Galina V. Yamshchikov in npj Vaccines (2017)

  2. Article

    Open Access

    Development of a mammalian cell culture process for rapid Clinical-Scale production of novel Influenza Nanoparticle vaccines

    Payal Biswas, Christian Trozado, James Lee, Richard M Schwartz in BMC Proceedings (2015)

  3. Article

    Open Access

    CHO-DHFR cell line development platform: Application of Clonepix and Automated Mini Bioreactor (AMBR) technologies to meet accelerated timelines

    Venkata R Mangalampalli, Dyane Wycuff, Mingzhong Chen, David Berlinger in BMC Proceedings (2015)